The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review

S Crosby, E Rajadurai, S Jan, R Holden… - Humanities and Social …, 2022 - nature.com
Governments have attempted to increase clinical trial activity in their jurisdictions using a
range of methods including simplifying the ethics review and governance process of clinical …

'Commercialising Traditional Medicine': Ayurvedic Manufacturing in Kerala

MS Harilal - Economic and political weekly, 2009 - JSTOR
This is an attempt to answer two questions on the manufacture of ayurvedic products in
Kerala. First, has the performance of the ayurvedic sector been impressive? Preliminary …

Globalization of the Indian pharmaceutical industry: implications for innovation

D Abrol, P Prajapati, N Singh - Institutions and Economies, 2011 - jpmm.um.edu.my
In this article we create an industry-wide metrics of innovation based on the characterization
of learning potential of foreign direct investment (FDI), technology acquisition and in-house …

The effects on clinical trial activity of direct funding and taxation policy interventions made by government: A systematic review

S Crosby, E Rajadurai, S Jan, B Neal, R Holden - Plos one, 2022 - journals.plos.org
Context Governments have attempted to increase clinical trial activity in their jurisdictions
using a range of methods including targeted direct funding and industry tax rebates. The …

Developmental states, civil society, and public health: Patent regulation for HIV/AIDS pharmaceuticals in India and Brazil

T Eimer, S Lütz - Regulation & Governance, 2010 - Wiley Online Library
Abstract While both India and Brazil are seriously affected by the HIV/AIDS epidemic, each
country has chosen a different approach to providing affordable pharmaceutical treatment …

Emerging Indian pharma multinationals: latecomer catch-up strategies in a globalised high-tech industry

G Bruche - European Journal of International Management, 2012 - inderscienceonline.com
Leading Indian Pharmaceutical Companies (IPCs) are frequently taken as prime examples
of the new 'emerging multinationals' from develo** countries. Business researchers have …

Policy, markets and knowledge: Strategic synergies in Indian pharmaceutical firms

K Chaturvedi, J Chataway, D Wield - Technology Analysis & …, 2007 - Taylor & Francis
This paper addresses the question of how Indian pharmaceutical firms have transformed
themselves from reverse-engineering firms focused on the domestic market to research …

Impact of entrepreneur on the sectoral system of innovation: Case study of the Indian crude oil refining industry

CG Iyer - Technological Forecasting and Social Change, 2016 - Elsevier
In this paper using the connectionist perspective of an entrepreneur we have tried to
highlight the importance of the entrepreneur and the role of the entrepreneur in initializing …

Technological capabilities and firm resources as determinants of export competitiveness: Evidence from Indian pharmaceutical industry using quantile regression …

S Rentala, B Anand, M Shaban - Journal of Medical …, 2014 - journals.sagepub.com
Technological capabilities of firms and other firm resources have been researched by many
researchers to assess their impact on export competitiveness of Indian industries. This study …

[PDF][PDF] The development of the pharmaceutical industry in Brazil and India: technological capability and industrial development

L Hasenclever, J Paranhos - … Institute, Federal University of Rio de …, 2009 - researchgate.net
Abstract The BRICS–Brazil, Russia, India, China and South Africa–are the five develo**
countries most analyzed and debated nowadays. Those countries have had a distinguished …